27 related articles for article (PubMed ID: 1194758)
1. Transfer of tumor specific immunity with "immune" RNA: prospects for the treatment of human cancer.
Fritze D; Kern DH; Pilch YH
Klin Wochenschr; 1976 Sep; 54(18):851-63. PubMed ID: 787654
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy of human malignancies with immune RNA.
DeKernion JB; Ramming KP; Pilch YH
World J Surg; 1977 Sep; 1(5):625-38. PubMed ID: 602235
[No Abstract] [Full Text] [Related]
3. Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. II. Immunologic parameters in vitro.
Waldman SR; Roth JA; Kern DH; Pilch YH
J Lab Clin Med; 1975 Dec; 86(6):950-61. PubMed ID: 127818
[TBL] [Abstract][Full Text] [Related]
4. Changes in immunological and virological parameters in HIV-1 infected subjects following leukapheresis.
Boulassel MR; Spurll G; Rouleau D; Tremblay C; Edwardes M; Sekaly RP; Lalonde R; Routy JP
J Clin Apher; 2003; 18(2):55-60. PubMed ID: 12874816
[TBL] [Abstract][Full Text] [Related]
5. Collection of peripheral blood stem cells using an automated discontinuous flow blood cell separator.
Pierelli L; Menichella G; Paoloni A; Teofili L; Sica S; Foddai ML; Rossi PL; Leone G; Mango G; Bizzi B
Haematologica; 1990; 75 Suppl 1():29-32. PubMed ID: 2351341
[TBL] [Abstract][Full Text] [Related]
6. [A new separation protocol (DRBCP-F) for automated blood component donation with the MCS 3p cell separator for collection of leukocyte depleted erythrocyte concentrates and plasma].
Zeiler T; Kretschmer V
Beitr Infusionsther Transfusionsmed; 1997; 34():118-22. PubMed ID: 9417335
[TBL] [Abstract][Full Text] [Related]
7. Clinical impact of a new automated system employed for peripheral blood stem cell collection.
Del Fante C; Perotti C; Viarengo G; Bellotti L; Parisi C; Marchesi A; Tinelli C; Salvaneschi L
J Clin Apher; 2006 Dec; 21(4):227-32. PubMed ID: 16847939
[TBL] [Abstract][Full Text] [Related]
8. Effects on cancer patients of leukapheresis with the continuous-flow blood cell separator. I. Hematologic and immunologic parameters in vivo.
Waldman SR; Roth JA; Silverstein M; Veltman LL; Pilch YH
J Lab Clin Med; 1975 Dec; 86(6):938-49. PubMed ID: 1194758
[TBL] [Abstract][Full Text] [Related]
9. Immunologic evaluation of patients with cancer by delayed hypersensitivity reactions.
Burdick JF; Wells SA; Herberman RB
Surg Gynecol Obstet; 1975 Nov; 141(5):779-94. PubMed ID: 128144
[TBL] [Abstract][Full Text] [Related]
10. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
11. Clinical applications of the continuous flow blood separator machine.
Oon CJ; Hobbs JR
Clin Exp Immunol; 1975 Apr; 20(1):1-16. PubMed ID: 1106917
[TBL] [Abstract][Full Text] [Related]
12. [Principles of and instruments for a continuous-flow blood cell separator---centrifugation].
Minato K; Shimoyama M; Kimura K
Nihon Rinsho; 1977 Dec; 35(12):4161-9. PubMed ID: 342758
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
